Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Mar 16, 2007 10:10am
386 Views
Post# 12430129

Did you notice ..................polak

Did you notice ..................polak Did you notice that FMR Co. refiled their NI62-103 on March 12 and corrected The Date ............. Amended Canadian Filing The attached filing has been amended and labeled as Corrected. Page 1 Part 3 has been amended to reflect the proper period for which the report is filed. Corrected March 12, 2007 EARLY WARNING REPORT UNDER THE ALTERNATIVE MONTHLY REPORTING SYSTEM OF NATIONAL INSTRUMENT 62-103 1. Name and address of the eligible institutional investor: Fidelity Management & Research Company (“FMR Co.”) 82 Devonshire Street Boston, MA, 02109 FMR Co. and certain other relevant affiliates and associates are sometimes hereinafter collectively referred to as “Fidelity.” 2. Name of the reporting issuer: Transition Therapeutics Inc. 3. Period for which the report is filed: Period ended January, 2007. blah blah blah.........
Bullboard Posts